Pressure BioSciences Reports New Client Launching Around UltraShear Nanoemulsions Platform with $300,000-plus Product Order
18. Januar 2024 11:26 ET
|
Pressure BioSciences, Inc.
With the Recent Acquisition of Its New Uncle Buds Business Unit, PBIO Expects Consumer Products to Continue Their Rapid Sales Acceleration
Pressure BioSciences’ New Consumer Products Unit Continues Long Sales Relationship with Dominant U.S. Retailer, Launching 2024 with Quarter Million Dollar Shipment in January
16. Januar 2024 08:47 ET
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a pioneer in the development and distribution of broadly enabling...
Zacks Small Cap Research Releases Updated Report on Pressure BioSciences, Inc.
30. Dezember 2019 08:34 ET
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Dec. 30, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling,...
Pressure BioSciences, Inc. Reports Third Quarter 2019 Financial Results and Provides Business Update
19. Dezember 2019 10:03 ET
|
Pressure BioSciences, Inc.
Significant Revenue Growth Reported in Consumable Products (158%) and Scientific Services (87%);Company Continues to Gain Momentum in Its PCT, BaroFold, and UST Technology Platforms Investor...
Pressure BioSciences, Inc. to Discuss Third Quarter 2019 Financial Results and Provide Business Update
18. Dezember 2019 08:00 ET
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Dec. 18, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”) today announced that the Company will host a...
Zacks Small Cap Research Initiates Coverage on Pressure BioSciences, Inc.
04. Oktober 2019 08:04 ET
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling,...
Pressure BioSciences’ Proprietary PCT Platform Fills Pivotal Role for Tumor Analyses in Novel Workflow Presented at Leading Global Gynecologic Cancer Meeting
01. Oktober 2019 07:30 ET
|
Pressure BioSciences, Inc.
SOUTH EASTON, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling,...
Pressure BioSciences’ PCT Platform Featured in Multiple Presentations at Major International Science Conference
26. September 2019 09:29 ET
|
Pressure BioSciences, Inc.
Ten Presentations by Scientists from Seventeen Research Institutions Worldwide Highlight Novel Applications for PBI’s PCT Platform in Cancer Research and Diagnostics South Easton, MA,...
Pressure BioSciences Prepares for Growth, Adding Daniel J. Shea as Chief Financial Officer
17. September 2019 10:33 ET
|
Pressure BioSciences, Inc.
Shea’s 30-Year Diverse Experience in Acquisitions, Capital Markets, SEC Reporting, and Leading Financial Organizations Bolsters PBI’s Strong Senior Management Team South Easton, MA, Sept. 17,...
Pressure BioSciences’ PCT Platform Identified as Pivotal for Cancer Biomarker Discovery and for Potential Clinical Diagnostics
10. September 2019 09:33 ET
|
Pressure BioSciences, Inc.
Two Prestigious Research Centers Report PBI’s PCT Platform Delivers Superior Results for Protein Biomarker Discovery Studies from Preserved Cancer Biopsy Tissue Samples SOUTH EASTON, MA,...